Myelopeptides
137833-32-0CC(C)C[C@H](NC(=O)[C@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)[C@@H](C)OGJQDTIRGBUXHLF-PKNHJBQWSA-NRN refers to myelopeptide 1; immune system peptides from bone marrow; act as analgesics and immunoregulators; MP-1 to MP-4 have been sequenced
137833-32-0DTXSID20160337Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
Compounds capable of relieving pain without the loss of CONSCIOUSNESS.
Biologically active substances whose activities affect or play a role in the functioning of the immune system.